| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/27/2009 | US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | US20090215750 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases |
| 08/27/2009 | US20090215746 Substituted pyrazolo[1,5-a]pyrimidines as calcium receptor modulating agents |
| 08/27/2009 | US20090215741 1H-Pyrimido[4,5-b]indole Derivatives, Their Preparation and Therapeutic Use |
| 08/27/2009 | US20090215724 Pyrrolopyrazine kinase inhibitors |
| 08/27/2009 | US20090215105 Tetraazaporphyrin-Based Compounds and Their Uses |
| 08/27/2009 | US20090214441 Lipophilic Chelates and Their Use in Imaging |
| 08/27/2009 | CA2716230A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 08/27/2009 | CA2715747A1 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging |
| 08/26/2009 | EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 08/26/2009 | EP2091952A1 Pyrazolo ý3, 4 -d¨pyrimidine p38 map kinase inhibitors |
| 08/26/2009 | EP2091533A1 Constrained spirocyclic compounds as cgrp receptor antagonists |
| 08/26/2009 | EP1883640B1 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group |
| 08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 08/26/2009 | EP1603910B1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1242851B1 Use of a composition in stereolithography |
| 08/26/2009 | CN101516888A Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 08/26/2009 | CN101516887A Thiazole pyrazolopyrimidines as CRF1 receptor antagonists |
| 08/26/2009 | CN101516886A Thiophene pyrazolopyrimidine compounds |
| 08/26/2009 | CN101516885A Pyrazolopyrimidines as PI3K lipid kinase inhibitors |
| 08/26/2009 | CN101516884A Octahydropyrrolo [3, 4-C] pyrrole derivatives an their use as antiviral agents |
| 08/26/2009 | CN101516883A Imidazopyrazines as protein kinase inhibitors |
| 08/26/2009 | CN101514206A 7a-(trifluoromethyl)-8,9-dihydro-7H-pyrrolo[1,2-a]perimidine-10(7alphaH)-ketone and synthetic method thereof |
| 08/26/2009 | CN101514205A 7a-(difluoromethyl)tetrahydro-1H-pyrrolo[1,2-alpha]imidazole-5(6H)-ketone and synthetic method thereof |
| 08/26/2009 | CN101514204A 7a-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-a]imidazole-5(6H)-ketone and synthetic method thereof |
| 08/26/2009 | CN101514203A 7-nitryl-3a-(trifluoromethyl)-2,3,3a,4-tetrahydrogen-1H-benzo(d) pyrrole (1,2-a) imidazole-1-ketone and synthesis method thereof |
| 08/26/2009 | CN101514202A 9a-(trifluoromethyl) hexahydrogen-1H-pyrrolo(1,2-a) diazepine-7(8H)-ketone and synthesis method thereof |
| 08/25/2009 | US7579482 Structure of camphor-derived chiral auxiliary and method for forming the same |
| 08/25/2009 | US7579470 3-(4-Chloro-phenyl)-2-methyl-2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene; serotonin receptor modulator; anxiolytic, antidepressant, antiinflammatory agent, analgesic; psychological, sleep, eating, bipolar, sexual disorders; schizophrenia, obesity, retinopathy |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
| 08/25/2009 | US7579374 Using fatty esters |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579356 Thia-tetraazaacenaphthylene kinase inhibitors |
| 08/25/2009 | US7579355 Inhibitors of Akt activity |
| 08/25/2009 | US7579344 Pyrimidine derivatives possessing cell-cycle inhibitors activity |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/25/2009 | US7579336 Pharmaceutical composition comprising temozolomide ester |
| 08/25/2009 | US7579124 Pyrazolotriazole ring containing dye for improving heat resistance and photostability, curable monomers, alkali soluble ibinders, photosensitive azide compound, a crosslinking agent |
| 08/25/2009 | CA2388163C Process for formulation of carbapenem antibiotic compositions |
| 08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
| 08/20/2009 | WO2009103032A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | WO2009102633A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102468A1 6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof |
| 08/20/2009 | WO2009101634A2 A novel process for the preparation of eszopiclone |
| 08/20/2009 | WO2009100996A2 Process for preparing pyrazole functionalized benzodiazepinones |
| 08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | WO2009100480A1 Use of sulfonated dye salt for modulating dye stability |
| 08/20/2009 | WO2009082268A3 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 08/20/2009 | WO2009079412A3 Reverse transcriptase inhibitors |
| 08/20/2009 | WO2009006075A3 Functionalized expanded porphyrins |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209610 Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-Phenyl-2,3-Dihydro-1h-Pyrrolizin-5-Ylacetic Acid |
| 08/20/2009 | US20090209571 Phenanthrene derivatives as MPGES-1 inhibitors |
| 08/20/2009 | US20090209566 Spirocyclic Compounds |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209557 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 08/20/2009 | US20090209545 Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 08/20/2009 | US20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 08/20/2009 | US20090209531 used for treating metabolic, nervous sytsem and skin disorders,inflammatory diseases, obesity, cachexia, erectile dysfunction, neuropathic pain, or as antidepressants, anxiolytic and anticarcinogenic agents |
| 08/20/2009 | US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/20/2009 | US20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) |
| 08/20/2009 | US20090209491 Lactams as conformationally constrained peptidomimetic inhibitors |
| 08/20/2009 | CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2714414A1 Certain substituted amides, method of making, and method of use thereof |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/20/2009 | CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | CA2707442A1 Antibiotic tetrahydro-beta-carboline derivatives |
| 08/19/2009 | EP2090579A1 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/19/2009 | EP2090578A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta |
| 08/19/2009 | EP2090577A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 08/19/2009 | EP2090576A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2089394A1 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 08/19/2009 | EP2089393A1 Heterocyclic compounds as antiinflammatory agents |
| 08/19/2009 | EP2089392A2 3-(dihydro-1h-pyrazolo ý4,3-d¨pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 08/19/2009 | EP2089391A2 Bruton's tyrosine kinase activity probe and method of using |
| 08/19/2009 | EP2089385A2 Inhibitors of hepatitis c virus |
| 08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
| 08/19/2009 | EP2089020A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/19/2009 | EP1478339B9 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 08/19/2009 | CN101511839A Fungicidal azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 08/19/2009 | CN101511838A A pyrrolopyrazin as SYK-kinase inhibitor |
| 08/19/2009 | CN101511837A Pyrrolopyrimidines for pharmaceutical compositions |
| 08/19/2009 | CN101511836A Fused pyrimido compounds |
| 08/19/2009 | CN101511835A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 08/19/2009 | CN101511834A Compound for organic electroluminescent device and organic electroluminescent device |
| 08/19/2009 | CN101511833A 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 08/19/2009 | CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase |
| 08/19/2009 | CN101511429A Indulines derivatives and gpr119 agonists |
| 08/19/2009 | CN101510590A Organic electroluminescent element and display |
| 08/19/2009 | CN101508849A Process for producing solvent of red 135 |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/19/2009 | CN100528877C New purine alkaloid and preparation method and application thereof |
| 08/19/2009 | CN100528876C Pyrrazolo-pyrimidine derivatives |